These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24328837)

  • 1. Romania's drug policy from 2005 to 2012: experiences with implementation.
    Dégi CL
    Subst Use Misuse; 2014 May; 49(6):677-83. PubMed ID: 24328837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of drug prevention system development in Romania and its impact on youth drug consumption trends, 1995-2005.
    Dégi CL
    Drug Alcohol Rev; 2009 Jul; 28(4):419-25. PubMed ID: 19594796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug policy in Vietnam: a decade of change?
    Vuong T; Ali R; Baldwin S; Mills S
    Int J Drug Policy; 2012 Jul; 23(4):319-26. PubMed ID: 22206713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing the Code of Practice on International Recruitment in Romania - exploring the current state of implementation and what Romania is doing to retain its domestic health workforce.
    Paina L; Ungureanu M; Olsavszky V
    Hum Resour Health; 2016 Jun; 14(Suppl 1):22. PubMed ID: 27381198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Political science, public policy, and drug use prevention.
    Pentz MA; Mares D; Schinke S; Rohrbach LA
    Subst Use Misuse; 2004; 39(10-12):1821-65. PubMed ID: 15587952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
    Moore D; Fraser S; Törrönen J; Tinghög ME
    Int J Drug Policy; 2015 Apr; 26(4):420-8. PubMed ID: 25662895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE
    Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reform of drug control policy for palliative care in Romania.
    Mosoiu D; Ryan KM; Joranson DE; Garthwaite JP
    Lancet; 2006 Jun; 367(9528):2110-7. PubMed ID: 16798394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An all-embracing problem description. The Swedish drug issue as a political catalyst 1982-2000.
    Edman J
    Int J Drug Policy; 2013 Nov; 24(6):558-65. PubMed ID: 23790617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policies for disease prevention in Germany in the European context: a comparative analysis.
    Gericke CA; Busse R
    J Public Health (Oxf); 2004 Sep; 26(3):230-8. PubMed ID: 15454589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the rhetoric: towards a more effective and humane drug policy framework in South Africa.
    Parry C; Myers B
    S Afr Med J; 2011 Oct; 101(10):704, 706. PubMed ID: 22329014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romania: changing the regulatory environment.
    Mosoiu D; Mungiu OC; Gigore B; Landon A
    J Pain Symptom Manage; 2007 May; 33(5):610-4. PubMed ID: 17482056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the harm of "harm reduction".
    Beirness DJ; Notarandrea R; Jesseman R; Perron M
    Clin Pharmacol Ther; 2008 Apr; 83(4):523-5. PubMed ID: 18349874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years after the United Nations General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposals.
    Reuter P
    Addiction; 2009 Apr; 104(4):510-7. PubMed ID: 19335650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician Leadership on National Drug Policy: advocacy for an effective drug policy.
    Lewis DC
    Med Health R I; 1999 Mar; 82(3):101-4. PubMed ID: 10193141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive education to cope with the drug problems of Latin America.
    Massun E
    Bull Narc; 1990; 42(1):49-55. PubMed ID: 2095936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.